What question did this study set out to answer?

To investigate whether rheumatoid arthritis affects the severity of liver disease and outcomes of antiviral treatment in chronic hepatitis C.

April 16, 2026Polskie Archiwum Medycyny Wewnętrznej0 citationsOpen Access

Does rheumatoid arthritis affect the course of chronic hepatitis C and outcomes of antiviral treatment?

KBKinga Brzdęk DZDorota Zarębska-Michaluk BLBeata Lorenc

Key Points

To investigate whether rheumatoid arthritis affects the severity of liver disease and outcomes of antiviral treatment in chronic hepatitis C.
Examined the relationship between rheumatoid arthritis and liver disease progression in chronic hepatitis C patients.
Evaluated the effectiveness and safety of direct-acting antiviral (DAA) therapy in this population.
Analyzed liver disease stage and hepatic dysfunction as key factors in treatment outcomes.
Rheumatoid arthritis does not worsen the severity of liver disease related to HCV.
DAA therapy is equally effective and safe for patients with rheumatoid arthritis as for those without it.
Liver disease stage and function are more critical than the presence of rheumatoid arthritis in determining treatment success.

Abstract

RA does not contribute to increased severity or progression of HCV-related liver disease and does not negatively affect the effectiveness or safety of DAA therapy. Liver disease stage and hepatic dysfunction, rather than the presence of RA, are the key determinants of treatment outcomes in patients with chronic HCV infection.

AIに質問

Bookmark

View Full Paper